Bill Gates is backing a company that has a novel way to treat disease
Exicure is building drugs out of RNA, or ribonucleic acid, that can silence mutated genes. Image: REUTERS/Joshua Roberts
Lydia Ramsey
Editorial Intern, Business Insider Science
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
Fourth Industrial Revolution
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on Fourth Industrial RevolutionSee all
Ester Faia, Gianmarco Ottaviano and Saverio Spinella
January 30, 2023
Daichi Iwata, Takanori Fujita and M.D. J.D.
January 18, 2023
January 18, 2023
Abhinav Chugh
January 14, 2023